Immunoglobulin pseudogene

Immunoglobulin pseudogenes, such as the one designated by ENSG00000283571, are sequences in the human genome that resemble immunoglobulin genes but have lost their protein-coding ability due to mutations such as frameshifts, insertions, deletions, or premature stop codons[1][3][5]. As pseudogenes, they do not encode a functional protein product, but in some organisms, immunoglobulin pseudogenes can contribute to immune system diversity by acting as templates during V(D)J recombination events or serve as reservoirs to enhance gene sequence diversity[4][5]. While pseudogenes were historically considered non-functional, recent research has identified regulatory roles in some cases, such as acting as decoys for microRNAs, serving as sources for small interfering RNAs, or modulating parental gene expression through antisense transcripts[2][5]. However, the vast majority of IG pseudogenes—including ENSG00000283571—do not have direct therapeutic, diagnostic, or pharmacological relevance and are not considered drug targets. Notes: - This record represents a gene annotated as “novel IG pseudogene,” specific to the Ensembl ID provided. It should not be confused with functional immunoglobulin genes that encode antibody chains. - By strict criteria, **pseudogenes are not considered drug targets**, enzymes, receptors, or transporters, since they lack protein-coding function and generally do not have a well-established, actionable biological role[1][5]. Summary: ENSG00000283571 (“novel IG pseudogene”) is a non-coding, immunoglobulin-related pseudogene. It is not a viable therapeutic target and does not encode any functional protein product, though regulatory RNA roles are hypothesized for some pseudogenes in general[2][4][5].

Other names

IG pseudogeneimmunoglobulin pseudogeneENSG00000283571